Package 51224-011-10

Brand: cholestyramine

Generic: cholestyramine
NDC Package

Package Facts

Identity

Package NDC 51224-011-10
Digits Only 5122401110
Product NDC 51224-011
Description

348.6 g in 1 CAN (51224-011-10)

Marketing

Marketing Status
Discontinued 2026-11-30
Brand cholestyramine
Generic cholestyramine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "94d7bc24-2f81-463b-b646-92fbf6641f71", "openfda": {"nui": ["N0000180292", "N0000175365"], "unii": ["4B33BGI082"], "rxcui": ["848943"], "spl_set_id": ["06261db5-1435-4b91-8b54-71bfcfb1368c"], "pharm_class_epc": ["Bile Acid Sequestrant [EPC]"], "pharm_class_moa": ["Bile-acid Binding Activity [MoA]"], "manufacturer_name": ["TAGI Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "348.6 g in 1 CAN (51224-011-10)", "package_ndc": "51224-011-10", "marketing_end_date": "20261130", "marketing_start_date": "20210310"}, {"sample": false, "description": "60 POUCH in 1 CARTON (51224-011-20)  / 8.3 g in 1 POUCH", "package_ndc": "51224-011-20", "marketing_end_date": "20261130", "marketing_start_date": "20210310"}], "brand_name": "Cholestyramine", "product_id": "51224-011_94d7bc24-2f81-463b-b646-92fbf6641f71", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Bile Acid Sequestrant [EPC]", "Bile-acid Binding Activity [MoA]"], "product_ndc": "51224-011", "generic_name": "Cholestyramine", "labeler_name": "TAGI Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cholestyramine", "active_ingredients": [{"name": "CHOLESTYRAMINE", "strength": "4 g/8.3g"}], "application_number": "ANDA209597", "marketing_category": "ANDA", "marketing_end_date": "20261130", "marketing_start_date": "20210310"}